Canada markets close in 5 hours 17 minutes

CVS Health Corporation (CVS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
96.91-0.89 (-0.91%)
As of 10:43AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close97.80
Open96.45
Bid96.99 x 800
Ask97.03 x 800
Day's Range95.78 - 97.51
52 Week Range79.33 - 111.25
Volume1,022,591
Avg. Volume5,613,453
Market Cap127.079B
Beta (5Y Monthly)0.77
PE Ratio (TTM)16.12
EPS (TTM)6.01
Earnings DateAug 03, 2022
Forward Dividend & Yield2.20 (2.26%)
Ex-Dividend DateApr 21, 2022
1y Target Est117.63
  • Reuters

    UPDATE 1-Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done

    Walmart Inc and CVS Health Corp said on Wednesday they will stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health. Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process. CVS said it will not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health."

  • Reuters

    Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done

    Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process. CVS said it would not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health." Cerebral had earlier this month decided to stop prescribing controlled substances and taper existing prescriptions based on the impending expiration of waivers, the company said in an emailed statement.

  • Reuters

    UPDATE 3-Walmart, CVS to halt filling prescriptions for controlled substances by Cerebral, Done

    Walmart Inc and CVS Health Corp said on Wednesday they would stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health. Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process. CVS said it would not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health."